Kennedy Capital Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $6.87M | Sell |
|
|||||
|
2025
Q2 | $8.09M | Sell |
|
|||||
|
2025
Q1 | $12.5M | Buy |
|
|||||
|
2024
Q4 | $11.7M | Sell |
|
|||||
|
2024
Q3 | $15.8M | Sell |
|
|||||
|
2024
Q2 | $22.2M | Sell |
|
|||||
|
2024
Q1 | $29.4M | Buy |
|
|||||
|
2023
Q4 | $23.4M | Buy |
|
|||||
|
2023
Q3 | $18.3M | Buy |
|
|||||
|
2023
Q2 | $19.4M | Buy |
|
|||||
|
2023
Q1 | $11.9M | Buy |
|
|||||
|
2022
Q4 | $10.9M | Buy |
|
|||||
|
2022
Q3 | $8.68M | Buy |
|
|||||
|
2022
Q2 | $8.24M | Buy |
|
|||||
|
2022
Q1 | $4.4M | Buy |
|
|||||
|
2021
Q4 | $5.46M | Sell |
|
|||||
|
2021
Q3 | $6.23M | Sell |
|
|||||
|
2021
Q2 | $5.93M | Sell |
|
|||||
|
2021
Q1 | $8.29M | Sell |
|
|||||
|
2020
Q4 | $8.17M | Sell |
|
|||||
|
2020
Q3 | $7.42M | Sell |
|
|||||
|
2020
Q2 | $6.2M | Buy |
|
|||||
|
2020
Q1 | $4.46M | Buy |
|
|||||
|
2019
Q4 | $2.7M | Buy |
|
|||||
|
2019
Q3 | $2.03M | Sell |
|
|||||
|
2019
Q2 | $2.31M | Buy |
|
|||||
|
2019
Q1 | $2.27M | Sell |
|
|||||
|
2018
Q4 | $4.89M | Sell |
|
|||||
|
2018
Q3 | $11.3M | Buy |
|
|||||
|
2018
Q2 | $9.15M | Buy |
|
|||||
|
2018
Q1 | $8.3M | Sell |
|
|||||
|
2017
Q4 | $8.65M | Buy |
|
|||||
|
2017
Q3 | $8.31M | Buy |
|
|||||
|
2017
Q2 | $7.21M | Buy |
|
|||||
|
2017
Q1 | $6.17M | Sell |
|
|||||
|
2016
Q4 | $5.23M | Buy |
|
|||||
|
2016
Q3 | $1.92M | Buy |
|
|||||
|
2016
Q2 | $1.66M | Buy |
|